Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"

Location of origin of the thromboembolytic event

Distribution in the number of patients according to the anatomical location affected by the thromboembolytic event.

Time frame: Baseline

Vessel of origin of the thromboembolytic event

Distribution in the number of patients according to the type of vessel affected by the thromboembolytic event.

Time frame: Baseline

Thromboembolytic event diagnosis type

Proportion of patients with incidental versus symptomatic thormboembolic events

Time frame: Baseline

Primary tumor at the time of the thromboembolic event

Distribution of patients according to the organ affected by the primary tumor.

Time frame: Baseline

Tumor-Node-Metastasis classification

Based on the American Joint Committee on Cancer 2018 Tumor-Node-Metastasis classification system: T for extent or size of the tumor, N for lymph nodes spread and M for metastasis.

Time frame: Baseline

Time between cancer diagnosis and thromboembolic event

Based on date on confirmed diagnosis of cancer (primary tumor) and date of thromboembolic event

Time frame: Baseline

Patient situation at the last visit

Number of patients with rethrombosis, bleeding, other complications, tumor progression or death.

Time frame: 12 months

Characteristics of treatment administered for cancer

Based on the number of patients prescribed with chemotherapy, radiation therapy, hormonal therapy, erythropoietin, transfusions, surgery, catheter, etc.